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OBJECTIVES This study was performed to determine whether hibernating myocardium is adaptive or is
destined to undergo progressive irreversible injury.
BACKGROUND Previous studies have suggested that hibernating myocardium eventually results in progressive
dysfunction. Since serial studies cannot be performed in humans, the temporal progression of
physiologic and structural adaptations was evaluated in pigs with hibernating myocardium.
METHODS Pigs were instrumented with a left anterior descending coronary artery (LAD) stenosis
(1.5 mm) and underwent physiologic studies three to five months later to quantify regional
function, perfusion and 18F-2-deoxyglucose (FDG) uptake. Viability was confirmed by
histology and contractile reserve.
RESULTS Hibernating myocardium was characterized by severe regional dysfunction (centerline score,
21.9 6 0.1), reduced resting subendocardial flow (LAD: 0.85 6 0.03 vs. normal: 1.02 6 0.03
ml/min/g, p , 0.01), critically reduced subendocardial flow reserve (adenosine flow: 1.04 6
0.09 ml/min/g, p 5 NS vs. rest; epinephrine flow: 0.88 6 0.07 ml/min/g, p 5 NS vs. rest)
and increased FDG uptake (0.022 6 0.002 vs. 0.014 6 0.001 ml/g/min, p , 0.01).
Physiologic parameters were not different among animals studied at three (93 6 1 days, n 5
27), four (118 6 2 days, n 5 26) or five months (150 6 6 days, n 5 9). Pathology revealed
a small increase in LAD connective tissue (6.4 6 0.4% vs. 4.0 6 0.2%, p , 0.001), with no
change over this time frame.
CONCLUSIONS Thus, physiologic and structural features of hibernating myocardium remain constant for at
least two months. The absence of functional deterioration or progressive fibrosis suggests that
hibernation is adaptive rather than an unstable physiology destined to progress to irreversible
injury. The stability of this model appears ideally suited for interventions targeted to improve
flow and function in chronically dysfunctional myocardium. (J Am Coll Cardiol 2001;37:
1989–95) © 2001 by the American College of Cardiology
The natural history of patients with viable, chronically
dysfunctional myocardium is controversial. While retro-
spective studies concur that revascularization improves
prognosis, the early survival after diagnosis in the absence of
revascularization is variable. Some studies have demon-
strated an increase in mortality within the first several
months of clinical presentation (1,2), whereas others found
early stability followed by an increased mortality after two to
three years (3). One of the hypotheses set forth to explain
the poor prognosis is that repetitive subendocardial ischemia
ultimately progresses to irreversible injury (4). Challenging
this are studies of patients with single-vessel disease in
which regional dysfunction occurs without reductions in
global left ventricular function. In this setting, pathological
evaluation has demonstrated limited fibrosis, a reversion to
a fetal myocyte phenotype and an absence of degenerative
changes (5–7).
Unfortunately, there are no longitudinal data regarding
the temporal progression of physiologic or pathologic ab-
normalities in patients with chronically dysfunctional myo-
cardium in which viability was confirmed by preserved
metabolism, contractile reserve or recovery of function after
revascularization. In addition, there is frequently no distinc-
tion made between viable, chronically dysfunctional myo-
cardium with reduced resting flow (hibernating myocar-
dium) (8,9) as compared with regions with normal resting
perfusion (chronically stunned myocardium) (10). While
both of these physiologic states develop in response to
episodes of reversible ischemia and chronic stunning can
eventually result in hibernating myocardium (10), the mo-
lecular mechanisms probably differ (11) and may differen-
tially affect the natural history of the disease.
Since the relation among physiologic variables, myocar-
dial fibrosis and survival cannot be studied in a prospective
fashion in patients, we evaluated the temporal progression
of flow, function, 18F-2-deoxyglucose (FDG) uptake and
fibrosis in an established porcine model of hibernating
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myocardium (9). We have previously reported that this
model gradually progresses to produce a critical reduction
in coronary flow reserve that results in a temporal
transition from viable dysfunctional myocardium with nor-
mal resting flow (chronic stunning) to viable dysfunctional
myocardium with depressed resting flow (chronic hiberna-
tion) over a period of three months (12). Whether this
remains stable, spontaneously improves or is associated with
progressive functional and structural deterioration is un-
known.
This study was designed to evaluate the temporal stability
of hibernating myocardium with the following three objec-
tives: first, we sought to determine whether endogenous
angiogenesis of the collateral circulation resulted in sponta-
neous improvement in coronary flow reserve and function in
hibernating myocardium; second, we quantified connective
tissue in these animals to test the hypothesis that hibernat-
ing myocardium is unstable and destined to progress to
structural fibrosis in the absence of revascularization; and
finally, we retrospectively evaluated survival in pigs with
viable, chronically dysfunctional myocardium to determine
if chronically stunned and hibernating myocardium affect
prognosis differently.
METHODS
All experimental procedures and protocols conformed to
institutional guidelines for the care and use of animals in
research. The initial instrumentation and experimental pro-
tocol have been previously published in detail (9,13). To
specifically evaluate temporal changes in this model, 29
juvenile pigs were instrumented with a 1.5 to 2.25 mm
Delran stenosis on the proximal left anterior descending
artery (LAD) and studied 124 6 28 days after instrumen-
tation. The results of the studies of these animals were
pooled with the results of studies of 41 animals previously
reported (9,13,14). All animals were instrumented in an
identical fashion and housed under similar conditions.
Animals were excluded for myocardial infarction encom-
passing .1% of the left ventricular mass (n 5 5) or if
microsphere measurements of absolute regional perfusion
were unavailable (n 5 3). Thus, 62 animals were included in
this study.
All studies were conducted in the closed-chest anesthe-
tized state as previously described (9,13,14). After an
overnight fast, anesthesia was induced with a Telazol
(tiletamine 50 mg/ml and zolazepam 50 mg/ml)/xylazine
(100 mg/ml) mixture (0.022 ml/kg intramuscularly) and
maintained with halothane or isoflurane (1% to 3%) sup-
plemented with additional Telazol/xylazine (0.011 ml/kg
intramuscularly as needed). Catheters were placed into the
left atrium (or left ventricle [LV]) for microsphere injections
and the LV for contrast ventriculography. Pressure and
reference withdrawal samples for microspheres were taken
from a carotid or femoral artery. Pharmacologic agents were
administered through a jugular vein. Animals were hepa-
rinized (100 U/kg intravascularly) and hemodynamics al-
lowed to equilibrate for approximately 30 min.
Regional perfusion was assessed with colored micro-
spheres (9,13,14). After resting flow measurements, myo-
cardial function was assessed with contrast ventriculography
(9,13,14), and anteroapical wall motion was quantified by
centerline analysis (12). Flow and function were then
evaluated during inotropic stimulation with a submaximal
epinephrine infusion titrated to increase heart rate by
approximately 40 beats/min (0.21 6 0.02 mg/kg/min intra-
vascularly). A final flow measurement was performed during
adenosine vasodilation (0.9 mg/kg/min intravascularly) with
phenylephrine titrated to maintain arterial pressure (6.8 6
0.4 mg/kg/min intravascularly). Caliper measurements of
stenosis severity were obtained during coronary angiography
(9,13). Angiography could not be performed in five pigs. In
pigs with an occluded LAD, collateral circulation was
semiquantitatively assessed using the following scoring sys-
tem: 0: no collaterals, 1: faint opacification of the LAD, 2:
delayed but complete opacification of the LAD, 3: rapid and
complete filling of the LAD (9).
A subgroup of animals (n 5 37) received FDG (1 to
3 mCi intravascularly) approximately 1 h after the last
pharmacologic intervention, as previously described (9,14).
After 45 min, the heart was arrested with intravenous KCI
and rapidly excised. A midventricular ring was divided into
12 full-thickness wedges, then subdivided into subendocar-
dial, midmyocardial and subepicardial layers. Samples were
weighed and counted at 511 keV with a germanium well
detector (Canberra Inc.) (9) or sodium iodide detector
(Model 1470, Wallac Inc.) (14). The same samples were
used for microsphere flow determinations as previously
described (9,14). Additional samples from the LAD and
normally perfused regions (n 5 52 each) were trichrome-
stained to quantify connective tissue by standard point
counting techniques (9,13,14).
Data analysis. Data are presented as the mean 6 SE. Flow
and FDG in the LAD and normal regions represent
weighted means for all samples within a given region
(9,12–14). Measurements in LAD and normally perfused
regions were compared using paired t tests. Differences
between interventions or between groups were assessed
using an analysis of variance and t tests with the Bonferroni
correction for multiple comparisons. A p value of ,0.05 was
considered statistically significant.
Abbreviations and Acronyms
EDP 5 end-diastolic pressure
EF 5 ejection fraction
FDG 5 18F-2-deoxyglucose
LAD 5 left anterior descending coronary artery
LV 5 left ventricle
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RESULTS
Pigs were grouped according to the time after initial
instrumentation (three months [75 to 104 days], mean 93 6
1 days, n 5 27; four months [105 to 134 days], mean 118 6
2 days, n 5 26; five months [.134 days], mean 150 6 6,
n 5 9). Hematocrit and blood gas values were no different
among groups (hematocrit: 0.33 6 0.01, pH: 7.40 6 0.00,
pCO2: 41.9 6 0.8, pO2: 490 6 12). Left ventriculography
demonstrated severe anterior hypokinesis (centerline score,
21.9 6 0.2; normal 5 0) with an average ejection fraction
(EF) of 49 6 1%. The proximal LAD was severely stenotic
with total occlusion and collateral-dependent myocardium
in the majority of animals (68%). Resting hemodynamics,
LAD stenosis severity, collateral score and ventricular func-
tion were no different over time (Table 1).
Paired samples from hibernating LAD and normal re-
mote regions were evaluated to quantify temporal changes
in myocardial connective tissue. Representative photomi-
crographs from animals studied at three, four and five
months are shown in Fig. 1. There was a small increase in
connective tissue staining in the hibernating LAD region as
compared with remote, normal myocardium in each group
(Table 2; average values: LAD: 6.4 6 0.4% vs. normal:
4.0 6 0.2%, p , 0.001). Most of this constituted an
increase in the normal collagen network since replacement
fibrosis was rare. Thus, there was no evidence of a time-
dependent increase in fibrosis or development of necrosis in
hibernating myocardium.
Like the pathologic and hemodynamic variables, regional
perfusion remained remarkably constant over this period
(Table 2). The flow distribution in the hibernating LAD
and normally perfused remote regions are plotted in Fig. 2.
There were no differences in resting flow or flow during
submaximal epinephrine infusion over time. Resting suben-
docardial flow was significantly reduced in comparison to
the corresponding normal region at each time point. During
Figure 1. Representative trichrome images from pigs with hibernating myocardium. Images from representative animals studied three, four or five months
after instrumentation were stained with Masson’s trichrome to facilitate quantification of connective tissue (blue). The left anterior descending coronary
artery regions (upper row) illustrate the generalized and diffuse connective tissue staining pattern that was present in hibernating myocardium. Total
connective tissue staining was slightly higher in hibernating myocardium as compared with the normally perfused region of the same animal (lower row).
Magnification 6003.
Table 1. Resting Hemodynamics, Stenosis Severity and Function
Heart Rate
(beats/min)
Systolic
Pressure
(mm Hg)
EDP
(mm Hg)
Stenosis
Severity
(%)
Collaterals
EF
(%)
Centerline Score
(Normal 5 0)L to L R to L
3 Months 83 6 3 127 6 4 16.3 6 1.0 94 6 2 2.6 6 0.1 1.9 6 0.2 50 6 2 21.9 6 0.2
4 Months 83 6 3 129 6 3 17.5 6 1.0 92 6 3 2.1 6 0.2 2.5 6 0.2 48 6 2 21.9 6 0.2
5 Months 82 6 5 144 6 4 18.3 6 1.5 98 6 2 2.5 6 0.5 2.3 6 0.3 52 6 4 21.7 6 0.2
EDP 5 left ventricular end-diastolic pressure; EF 5 ejection fraction.
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submaximal epinephrine infusion, heart rate increased to
125 6 3 beats/min (p , 0.01 vs. rest) with no change in LV
systolic (131 6 3 mm Hg) or end-diastolic pressure (EDP)
(15.9 6 0.9 mm Hg). This submaximal increase in demand
resulted in an approximately 50% increase in flow in
normally perfused myocardium. In contrast, subendocardial
flow to the LAD region was unable to increase significantly
above resting values (Fig. 2). Despite this, indexes of global
function (EF: 49 6 1% to 56 6 2%, p , 0.001) and anterior
wall motion (centerline score: 21.9 6 0.1 to 21.2 6 0.1,
p , 0.001) improved with inotropic stimulation confirming
viability.
During adenosine infusion, heart rate (83 6 2 to 88 6 2
beats/min, p , 0.01) and LV EDP (17.0 6 0.6 to 19.4 6
0.8 mm Hg, p , 0.01) were slightly increased over control
values with no change in systolic pressure (130 6 2 to 133 6
3 mm Hg, p 5 NS). Vasodilation resulted in five- to
six-fold increases in flow to the normal region (Fig. 2). In
contrast, subendocardial LAD flow did not increase over
resting values (Table 2, Fig. 2). There were no differences in
hemodynamics or adenosine flow among animals studied at
the three time points. In addition, when only animals with
an occluded LAD were evaluated, there were no temporal
changes in regional flow at rest or during vasodilation. Thus,
pigs with hibernating myocardium developed a critical
impairment of subendocardial flow reserve that remained
stable for at least two months.
18F-2-deoxyglucose administered in the fasting state
resulted in regionally increased deposition at each time
point (Fig. 3). Full-thickness FDG deposition averaged
59% higher in the hibernating LAD region than in the
normally-perfused remote region. There was a pronounced
transmural gradient in each group (Fig. 3) with the greatest
regional increase in the LAD subendocardium (two-fold).
There were no significant differences among groups, and the
relative increase in FDG remained unchanged over time
(r2 5 0.03, p 5 NS).
Finally, the relationship between mortality before and
after the development of hibernating myocardium was
assessed using all of the animals instrumented for this study
and a study in which animals were evaluated up to two
months after instrumentation (9,12–15). Figure 4 illustrates
the Kaplan-Meier survival curve in pigs instrumented with
a chronic LAD stenosis. The perioperative mortality was
quite low. Almost all of the deaths were sudden with no
evidence of recent or healed myocardial infarction (unpub-
lished observations). Most deaths occurred before the de-
velopment of hibernating myocardium at three months.
DISCUSSION
There are three major new findings from this investigation.
First, intrinsic angiogenesis was insufficient to result in
spontaneous improvement in the physiologic abnormalities
associated with hibernating myocardium, and regional flow
reserve, function and FDG uptake remained unchanged
over at least two months. Second, we found no evidence of
progressive structural injury in hibernating myocardium.
Connective tissue content remained low and did not in-
crease over the period of study. Finally, while sudden death
was common in this model, it frequently occurred before the
development of hibernating myocardium. The stability of
the physiologic and pathologic findings over this time frame
indicate that the untoward short-term prognosis of patients
with viable, chronically dysfunctional myocardium is not
explained by progressive fibrosis or deterioration in func-
tion. On the contrary, they support the view that hibernat-
ing myocardium is an adaptive response that can be stable
over at least the two-month time frame evaluated in our
study.
Lack of pathologic progression in hibernating myocar-
dium. Previous studies have demonstrated that increased
connective tissue in chronically dysfunctional myocardium is
a major determinant of reversibility (6,16). Schwarz et al. (4)
attempted to estimate the duration of hibernation before
revascularization in patients with globally reduced LV
function. They concluded that a longer duration of clinical
symptoms (.50 days) was associated with lower preopera-
tive function and greater degrees of myocyte degeneration
and fibrosis. Not surprisingly, they and others have found
that patients with the most fibrosis had the worst recovery of
function after revascularization (6,16). A similar, progres-
sive increase in regional fibrosis and global dysfunction was
also supported by a study of prolonged, moderate ischemia
in pigs (17). While these data do not directly address the
structural and functional stability of hibernating myocar-
dium, they have supported the conclusion that hibernating
Table 2. Subendocardial Perfusion (ml/min/g) and Connective Tissue Staining (%)
n Rest n Epinephrine n Adenosine n
Connective
Tissue
3 Months LAD 27 0.82 6 0.05* 25 0.80 6 0.08* 27 1.05 6 0.14* 21 6.0 6 0.6*
Normal 1.03 6 0.06 1.53 6 0.09† 4.29 6 0.22† 3.8 6 0.3
4 Months LAD 26 0.90 6 0.06* 21 0.98 6 0.12* 26 1.06 6 0.16* 22 6.9 6 4.4*
Normal 1.02 6 0.05 1.49 6 0.11† 4.18 6 0.27† 4.4 6 0.4
5 Months LAD 9 0.79 6 0.06* 5 0.85 6 0.15* 7 0.97 6 0.11* 9 6.4 6 1.1
Normal 1.00 6 0.09 1.35 6 0.15† 4.31 6 0.62† 3.7 6 0.7
*p , 0.05 vs. normal; †p , 0.05 vs. rest.
LAD 5 left anterior descending coronary artery.
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myocardium requires immediate revascularization since it is
destined to undergo inexorable progression to fibrosis.
Other studies in patients with collateral-dependent myo-
cardium and single-vessel coronary artery disease have
shown less pronounced increases in connective tissue in
hibernating myocardium, and the structural changes suggest
a reversion to a fetal myocyte phenotype in response to stress
(5,6,16). These findings have led other investigators to
hypothesize that hibernating myocardium is an adaptive
mechanism to preserve myocyte viability in the setting of a
chronic limitation in coronary flow reserve. Our data sup-
port this latter concept in that the regional increase in
connective tissue in our porcine model of hibernating
myocardium was similar to that reported in humans with
collateral-dependent myocardium (7). Importantly, we
found no progression in fibrosis despite a chronic limitation
in subendocardial flow reserve over a two-month time
frame. These observations indicate that myocardial fibrosis
does not progress over the short term nor does progressive
LV dysfunction over this time frame account for the poor
survival attributed to viable, chronically dysfunctional myo-
cardium. Thus, the discordant degree of reported fibrosis
among clinical studies is likely related to evaluating different
patient populations. Coexisting fibrosis from subendocardial
infarction or progressive fibrosis from global LV dysfunc-
tion may be confounding factors in patients with ischemic
cardiomyopathy and depressed EFs versus patients with
regional dysfunction from single-vessel coronary artery disease.
Stability of physiologic abnormalities in hibernating
myocardium. The stability of resting and vasodilated cor-
onary flow in this model, characterized by the frequent
presence of collateral-dependent myocardium, supports the
notion that intrinsic stimuli to promote angiogenesis are
insufficient to result in spontaneous functional improvement
in pigs with hibernating myocardium. This lack of sponta-
neous improvement in coronary flow reserve contrasts with
several other animal models that employed ameroid occlu-
sion to stimulate coronary collateral growth. Canty and
Klocke (18) produced a state of chronic stunning that was
followed by relative reductions in resting flow and function
consistent with hibernating myocardium in dogs with lim-
ited collateral vasodilator reserve. Nevertheless, in this
model, spontaneous angiogenesis over a period of three
weeks resulted in the normalization of function that re-
flected the rapid improvement in collateral vasodilator
reserve.
O’Konski et al. (19) evaluated flow during exercise and
dipyridamole vasodilation 24 days after instrumenting pigs
Figure 2. Transmural distribution of regional perfusion in pigs with
hibernating myocardium. Microsphere measurements of perfusion at rest
(black circles), during submaximal epinephrine infusion (white diamonds)
and during adenosine vasodilation (black squares) are presented for the
normal remote region (upper graph) and the hibernating LAD region
(lower graph). Flow values for each condition were nearly identical in the
LAD and normal regions at each time point. A critical impairment of
subendocardial flow reserve was present in each group with vasodilated flow
unable to increase over resting values. The degree of vasodilation and the
transmural pattern of distribution was the same in each group demonstrat-
ing stable coronary physiology over the course of the study. LAD 5 left
anterior descending coronary artery.
Figure 3. Transmural distribution of regional FDG deposition in pigs with
hibernating myocardium. There was a marked transmural gradient in FDG
deposition (extraction 3 flow) in the hibernating LAD regions (black
squares) with regionally increased deposition in the inner two-thirds of the
myocardial wall in each group. There were no significant differences in
FDG deposition between groups of animals (3 months, n 5 12; 4 months,
n 5 18; 5 months, n 5 6) in any region or mural layer. FDG 5
18F-2-deoxyglucose; LAD 5 left anterior descending coronary artery.
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with a circumflex ameroid occluder. Flow during dipyrida-
mole increased to over 2 ml/min/g as compared with 3 to 4
ml/min/g in remote myocardium. While reduced, vasodi-
lated flow was much higher than what we found in pigs with
hibernating myocardium in this study (approximately 1
ml/min/g). White et al. (20) evaluated temporal changes in
adenosine flow reserve in pigs with a circumflex ameroid
studied up to four months after instrumentation. Subepi-
cardial flow during adenosine was not reduced as compared
with normal remote regions or sham control pigs. Suben-
docardial adenosine flow increased from a nadir of 1.04
ml/min/g at three weeks to 1.42 ml/min/g 13 weeks after
ameroid placement. While this was still reduced, maximum
subendocardial flow in shams only increased to 1.64 ml/
min/g because of adenosine-induced hypotension. In this
study, both subendocardial and subepicardial flow were
severely reduced in comparison with normal remote regions
(Fig. 2). Differences in perfusion pressure make it impossi-
ble to directly compare the results of White et al. (20) with
ours; however, estimates of vasodilated coronary vascular
resistance in this study were two-fold higher than those in
the circumflex ameroid model (approximately 90 vs. 45 mm
Hg/ml/min/g). As summarized in Table 2, vasodilated flow
remained constant in our model for at least two months.
This difference in collateral flow reserve in pigs with a
fixed LAD stenosis versus circumflex ameroid occlusion
likely reflects two factors. First, collateral flow per gram is
partially determined by the size of the risk region (21), and
the LAD perfusion territory is much larger than that of the
circumflex (22). Second, the porcine circumflex ameroid
model is associated with extracardiac collaterals from the
descending thoracic aorta that may contribute to higher
collateral flow reserve (20). These differences could explain
why porcine circumflex ameroid models do not usually
develop reductions in resting flow typical of hibernating
myocardium (23). Thus, the chronic critical limitation in
flow reserve in our model indicates that it will be useful to
examine interventions intended to modulate regional flow
and function in hibernating myocardium.
Temporal progression of viable, chronically dysfunc-
tional myocardium and survival. We have previously
demonstrated that there is a progression from chronically
stunned to hibernating myocardium during progressive
LAD stenosis in pigs. As early as one month after instru-
mentation, limited subendocardial flow reserve resulted in
regional dysfunction associated with normal resting flow
and normal FDG uptake (12). As coronary flow reserve fell
further at two months, FDG uptake increased, but resting
flow continued to be normal (12). Both time points dem-
onstrated regional dysfunction with normal resting flow
consistent with chronic stunning. Thereafter, the physio-
logic findings of hibernating myocardium developed and, as
demonstrated in this study, remained stable for up to five
months. This systematic temporal progression supports the
view that impaired coronary flow reserve is the primary
determinant of resting contractile dysfunction and the
phenotypic changes of hibernating myocardium. Indeed, we
have recently demonstrated that the temporal progression
can be contracted from three months to two weeks by
critically reducing flow reserve to values slightly greater than
resting flow in chronically instrumented pigs (24).
As shown in Fig. 4, there was a risk of sudden death in
this model that began approximately two weeks after instru-
mentation. Interestingly, much of the mortality occurred
before the development of hibernating myocardium at three
months. The transition period from chronic stunning to
hibernation appears to be a particularly vulnerable time for
spontaneous, ischemia-induced sudden death. Clinical
studies do not typically characterize the time course of
physiologic abnormalities nor do they distinguish between
chronically stunned and hibernating myocardium. This
could partially explain the differences in short-term prog-
nosis of patients with viable, chronically dysfunctional
myocardium (1,3). Unfortunately, we cannot comment on
any benefits of therapy to reduce ischemia, such as the
clinically held notion that revascularization may improve
survival in this patient population.
Methodologic limitations. Although we found that the
physiologic and pathologic findings of hibernating myocar-
dium were stable between three and five months after
instrumentation in this model, we cannot exclude the
possibility that spontaneous improvement or progressive
dysfunction might occur at a later time point. In addition,
we are unable to comment on the stability of dysfunction in
individual animals and to what extent acute stunning may be
superimposed on chronic hibernation (25). Finally, this
study does not specifically address the mechanism(s) for the
stability of hibernating myocardium, and it is unclear
whether some of the adaptations responsible for this involve
signaling pathways that are similar to those of ischemic
preconditioning.
Figure 4. Survival in pigs chronically instrumented with a fixed left anterior
descending coronary artery stenosis. The Kaplan-Meier Curve and the 95%
confidence intervals for the line illustrate the temporal progression of
survival for this model. The total number of animals at each time is shown
in parentheses. See text for discussion.
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Summary. Our results demonstrate remarkable stability of
the physiologic and structural alterations in hibernating
myocardium and, thus, are at odds with the hypothesis that
hibernating myocardium is inherently destined to undergo
progressive fibrosis and structural degeneration (4,17).
Rather, our findings support the notion that hibernating
myocardium is an intrinsic myocardial adaptation to prevent
progressive irreversible injury in the setting of chronic
repetitive ischemia (10,26). Like clinical studies, our data
indicate that there is an increased risk for sudden cardiac
death with viable, chronically dysfunctional myocardium.
Further studies will be required to determine whether this is
due to ventricular arrhythmias arising from transient isch-
emia or the result of cellular and structural remodeling that
we have previously demonstrated in hibernating myocar-
dium (13,15). Finally, in contrast with ameroid models in
pigs and dogs that show an improvement in flow and
function due to spontaneous angiogenesis over a period of
several weeks, our findings show stable coronary flow reserve
and function for at least two months. Thus, this model may
be ideally suited to study pharmacologic and mechanical
interventions intended to improve flow and function in
viable, chronically dysfunctional myocardium.
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